Dear Colleague,
We invite you to join us in the beautiful city of Amsterdam, 24-26 February 2012, to attend the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice. In its eight year, the Congress encompasses hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management option
s. The focus of the 2012 Congress is to provide a forum to review state-of-the-art and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field. Last year’s congress, held in Budapest, Hungary, was attended by hematology, oncology, and other healthcare-related professionals from nearly 40 countries, all of whom increased their knowledge and have changed their approach to disease management. Their highly positive review of the educational content, quality of speakers, and presentation excellence attests to the overall satisfaction of the attendees—and the value of continuing with a comprehensive update on hematologic oncology management. We hope you will join us in this beautiful and historic city for a stimulating and enjoyable Congress, as this meeting promises to be an exciting, interactive and educational experience for all attendees! Sincerely,
Bertrand Coiffier, MD, Chair
Eva Kimby, MD, PhD, Chair
Registration is now open: https://www.signup4.net/Public/ap.aspx?EID=A27910E
